Related references
Note: Only part of the references are listed.Expression, regulation and function of the ISGylation system in prostate cancer
A. Kiessling et al.
ONCOGENE (2009)
Atypical ubiquitin chains: new molecular signals - 'Protein modifications: Beyond the usual suspects' review series
Fumiyo Ikeda et al.
EMBO REPORTS (2008)
A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes
Chao-Po Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ISG15 as a novel tumor biomarker for drug sensitivity
Shyamal D. Desai et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum
Benjamin Fricke et al.
EMBO REPORTS (2007)
The proteasome is involved in determining differential utilization of double-strand break repair pathways
K. Gudmundsdottir et al.
ONCOGENE (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells
Yasuhiro Murakawa et al.
CANCER RESEARCH (2007)
The intra-S-phase checkpoint affects both DNA replication initiation and elongation: Single-cell and -DNA fiber analyses
Jennifer A. Seiler et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks
Haruyuki Takemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study
Maria-Victoria Mateos et al.
BLOOD (2006)
Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis
Emanuela Aleo et al.
CANCER RESEARCH (2006)
Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer
J. B. Andersen et al.
BRITISH JOURNAL OF CANCER (2006)
Elevated expression of IS615 in tumor cells interferes with the ubiquitin/26S proteasome pathway
SD Desai et al.
CANCER RESEARCH (2006)
Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages
H Interthal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genotoxic stress targets human Chk1 for degradation by the ubipuitin-proteasome pathway
YW Zhang et al.
MOLECULAR CELL (2005)
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
F Pajonk et al.
BMC CANCER (2005)
Chromatin in need of a fix: Phosphorylation of H2AX connects chromatin to DNA repair
C Thiriet et al.
MOLECULAR CELL (2005)
Cullin 3 promotes proteasomal degradation of the topoisomerase I-DNA covalent complex
HF Zhang et al.
CANCER RESEARCH (2004)
Proteasome involvement in the repair of DNA double-strand breaks
NJ Krogan et al.
MOLECULAR CELL (2004)
Ubiquitin-proteasome system - Ubiquitin-free routes into the proteasome
MA Hoyt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes
T Furuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
SD Desai et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
N Mitsiades et al.
BLOOD (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase
L Debethune et al.
NUCLEIC ACIDS RESEARCH (2002)
26 S proteasome-mediated degradation of topoisomerase II cleavable complexes
Y Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tumor cell death induced by topoisomerase-targeting drugs
TK Li et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors
EG Mimnaugh et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Conversion of topoisomerase 1 cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff
D Strumberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
